Market closed
Synaptogenix Inc./$SNPX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
Ticker
$SNPX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
4
Website
SNPX Metrics
BasicAdvanced
$2.9M
-
-$10.99
1.30
-
Price and volume
Market cap
$2.9M
Beta
1.3
52-week high
$3.31
52-week low
$1.84
Average daily volume
11K
Financial strength
Current ratio
17.472
Quick ratio
17.408
Management effectiveness
Return on assets (TTM)
-17.43%
Return on equity (TTM)
-78.91%
Valuation
Price to book
0.49
Price to tangible book (TTM)
0.49
Price to free cash flow (TTM)
-0.447
Growth
Earnings per share change (TTM)
-62.82%
3-year earnings per share growth (CAGR)
-44.09%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Synaptogenix Inc. stock?
Synaptogenix Inc. (SNPX) has a market cap of $2.9M as of April 20, 2025.
What is the P/E ratio for Synaptogenix Inc. stock?
The price to earnings (P/E) ratio for Synaptogenix Inc. (SNPX) stock is 0 as of April 20, 2025.
Does Synaptogenix Inc. stock pay dividends?
No, Synaptogenix Inc. (SNPX) stock does not pay dividends to its shareholders as of April 20, 2025.
When is the next Synaptogenix Inc. dividend payment date?
Synaptogenix Inc. (SNPX) stock does not pay dividends to its shareholders.
What is the beta indicator for Synaptogenix Inc.?
Synaptogenix Inc. (SNPX) has a beta rating of 1.3. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.